Literature DB >> 1385765

IL-6 enhances the generation of cytolytic T lymphocytes in the allogeneic mixed leucocyte reaction.

J E Ming1, R M Steinman, A Granelli-Piperno.   

Abstract

Cytolytic T lymphocytes (CTL) require soluble proteins termed lymphokines to develop lytic activity. In this report we have studied two of the lymphokines involved in the development of CTL during the allogeneic mixed leucocyte reaction (MLR). High doses of dendritic cells induced lytic activity from purified CD8+ cells in both the murine and human MLR. Under these conditions, IL-2 and IL-6 were endogenously produced and secreted. Antibodies to IL-2 or the IL-2 receptor blocked CTL formation; however, anti-IL-6 receptor antibodies only partially inhibited the response while anti-IL-6 antibodies were largely ineffective. When limiting numbers of antigen-presenting cells were used CTL failed to develop, and neither IL-2 nor IL-6 was secreted into the culture supernatant. Although the addition of IL-6 to such cultures was ineffective in generating CTL, the combination of IL-2 and IL-6 resulted in a 4-5-fold increase in lytic activity over that of IL-2 alone. We conclude that in the allogeneic MLR, IL-2 and IL-6 contribute to the generation of lytically active CD8+ cells, and the effect of IL-6 is evident when the dose of antigen-presenting cell is limited.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385765      PMCID: PMC1554396          DOI: 10.1111/j.1365-2249.1992.tb06894.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Distinctive features in the production of IL-6 by human T cells.

Authors:  J E Ming; A Granelli-Piperno
Journal:  Cell Immunol       Date:  1990-10-15       Impact factor: 4.868

2.  Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies.

Authors:  Y Hirata; T Taga; M Hibi; N Nakano; T Hirano; T Kishimoto
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

3.  Accessory signals in murine cytolytic T cell responses. Dual requirement for IL-1 and IL-6.

Authors:  J C Renauld; A Vink; J Van Snick
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

4.  The distinct surface of human blood dendritic cells, as observed after an improved isolation method.

Authors:  P S Freudenthal; R M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells.

Authors:  M A Holsti; D H Raulet
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

6.  Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor.

Authors:  A Vink; C Uyttenhove; P Wauters; J Van Snick
Journal:  Eur J Immunol       Date:  1990-01       Impact factor: 5.532

7.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

8.  Interleukin 6 is the principal cytolytic T lymphocyte differentiation factor for thymocytes in human leukocyte conditioned medium.

Authors:  J E Ming; C Cernetti; R M Steinman; A Granelli-Piperno
Journal:  J Mol Cell Immunol       Date:  1989

9.  IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation.

Authors:  K Lorré; J Van Damme; J Verwilghen; M L Baroja; J L Ceuppens
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

10.  Macrophage factors which enhance the mixed leukocyte reaction initiated by dendritic cells.

Authors:  K Naito; K Inaba; Y Hirayama; M Inaba-Miyama; T Sudo; S Muramatsu
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

View more
  10 in total

1.  Cd14 SNPs regulate the innate immune response.

Authors:  Hong-Hsing Liu; Yajing Hu; Ming Zheng; Megan M Suhoski; Edgar G Engleman; David L Dill; Matt Hudnall; Jianmei Wang; Rosanne Spolski; Warren J Leonard; Gary Peltz
Journal:  Mol Immunol       Date:  2012-03-23       Impact factor: 4.407

2.  Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses.

Authors:  Brian C Betts; Erin T St Angelo; Michael Kennedy; James W Young
Journal:  Blood       Date:  2011-09-22       Impact factor: 22.113

3.  Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.

Authors:  I S Leal; B Smedegârd; P Andersen; R Appelberg
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  IL-6 promotes cardiac graft rejection mediated by CD4+ cells.

Authors:  Adam Jared Booth; Svetlana Grabauskiene; Sherri Chan Wood; Guanyi Lu; Bryna E Burrell; D Keith Bishop
Journal:  J Immunol       Date:  2011-10-24       Impact factor: 5.422

Review 5.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

6.  Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice.

Authors:  R Appelberg; A G Castro; J Pedrosa; P Minóprio
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

7.  Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen.

Authors:  Brian C Betts; Omar Abdel-Wahab; Shane A Curran; Erin T St Angelo; Priya Koppikar; Glenn Heller; Ross L Levine; James W Young
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

8.  Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling.

Authors:  T K Teague; B C Schaefer; D Hildeman; J Bender; T Mitchell; J W Kappler; P Marrack
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

9.  Adipose stromal vascular fraction attenuates TH1 cell-mediated pathology in a model of multiple sclerosis.

Authors:  Annie C Bowles; Rachel M Wise; Brittany Y Gerstein; Robert C Thomas; Roberto Ogelman; Regan C Manayan; Bruce A Bunnell
Journal:  J Neuroinflammation       Date:  2018-03-13       Impact factor: 8.322

10.  Interferon-α-Induced Dendritic Cells Generated with Human Platelet Lysate Exhibit Elevated Antigen Presenting Ability to Cytotoxic T Lymphocytes.

Authors:  Ippei Date; Terutsugu Koya; Takuya Sakamoto; Misa Togi; Haruhiko Kawaguchi; Asuka Watanabe; Tomohisa Kato; Shigetaka Shimodaira
Journal:  Vaccines (Basel)       Date:  2020-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.